nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—FGF1—corneal epithelium—ocular cancer	0.174	0.355	CbGeAlD
Amlexanox—FGF1—cornea—ocular cancer	0.127	0.259	CbGeAlD
Amlexanox—IL3—lymphoid tissue—ocular cancer	0.0376	0.0768	CbGeAlD
Amlexanox—S100A13—eye—ocular cancer	0.0253	0.0518	CbGeAlD
Amlexanox—S100A13—epithelium—ocular cancer	0.0232	0.0473	CbGeAlD
Amlexanox—S100A12—epithelium—ocular cancer	0.0229	0.0467	CbGeAlD
Amlexanox—S100A12—lymphoid tissue—ocular cancer	0.0176	0.036	CbGeAlD
Amlexanox—FGF1—eye—ocular cancer	0.0156	0.0319	CbGeAlD
Amlexanox—FGF1—retina—ocular cancer	0.0155	0.0316	CbGeAlD
Amlexanox—FGF1—epithelium—ocular cancer	0.0143	0.0291	CbGeAlD
Amlexanox—FGF1—lymphoid tissue—ocular cancer	0.011	0.0224	CbGeAlD
Amlexanox—PDE4B—lymphoid tissue—ocular cancer	0.0062	0.0127	CbGeAlD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—CDKN1B—ocular cancer	0.000835	0.00163	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—GNA11—ocular cancer	0.000823	0.00161	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—E2F5—ocular cancer	0.000822	0.00161	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000818	0.0016	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SAG—ocular cancer	0.000818	0.0016	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—E2F4—ocular cancer	0.000805	0.00158	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—CDKN1A—ocular cancer	0.000805	0.00158	CbGpPWpGaD
Amlexanox—FGF1—PI-3K cascade—AKT1—ocular cancer	0.000802	0.00157	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—GNAQ—ocular cancer	0.000798	0.00156	CbGpPWpGaD
Amlexanox—FGF1—Signaling by Insulin receptor—HRAS—ocular cancer	0.000794	0.00156	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—GNA11—ocular cancer	0.000791	0.00155	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RBL1—ocular cancer	0.00079	0.00155	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—E2F3—ocular cancer	0.000787	0.00154	CbGpPWpGaD
Amlexanox—FGF1—PI3K/AKT activation—AKT1—ocular cancer	0.000783	0.00153	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—GNA11—ocular cancer	0.000783	0.00153	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—E2F5—ocular cancer	0.000783	0.00153	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—EP300—ocular cancer	0.00078	0.00153	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000779	0.00152	CbGpPWpGaD
Amlexanox—FGF1—GAB1 signalosome—AKT1—ocular cancer	0.000777	0.00152	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.00077	0.00151	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—E2F4—ocular cancer	0.000767	0.0015	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—GNAQ—ocular cancer	0.000765	0.0015	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SAG—ocular cancer	0.000763	0.00149	CbGpPWpGaD
Amlexanox—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—ocular cancer	0.000759	0.00149	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RBL1—ocular cancer	0.000752	0.00147	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—GNA11—ocular cancer	0.000747	0.00146	CbGpPWpGaD
Amlexanox—FGF1—Disease—TFDP1—ocular cancer	0.000747	0.00146	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—GNAQ—ocular cancer	0.000736	0.00144	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TFDP1—ocular cancer	0.000731	0.00143	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—GNAQ—ocular cancer	0.000728	0.00143	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—GNA11—ocular cancer	0.000725	0.00142	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—E2F5—ocular cancer	0.000724	0.00142	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—GNA11—ocular cancer	0.000711	0.00139	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—E2F4—ocular cancer	0.000709	0.00139	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—MDM2—ocular cancer	0.000703	0.00138	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—MDM2—ocular cancer	0.000702	0.00137	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RBL1—ocular cancer	0.000696	0.00136	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—GNAQ—ocular cancer	0.000695	0.00136	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—E2F3—ocular cancer	0.000685	0.00134	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—HRAS—ocular cancer	0.000679	0.00133	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000679	0.00133	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TGFB1—ocular cancer	0.000678	0.00133	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000677	0.00133	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—E2F5—ocular cancer	0.000675	0.00132	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—GNAQ—ocular cancer	0.000674	0.00132	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HDAC1—ocular cancer	0.000663	0.0013	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—E2F4—ocular cancer	0.000661	0.0013	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—GNAQ—ocular cancer	0.000661	0.00129	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—GNA11—ocular cancer	0.000658	0.00129	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—E2F3—ocular cancer	0.000652	0.00128	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.00065	0.00127	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RBL1—ocular cancer	0.000649	0.00127	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—CDKN1B—ocular cancer	0.000642	0.00126	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CDKN1B—ocular cancer	0.000641	0.00125	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—HRAS—ocular cancer	0.00064	0.00125	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TFDP1—ocular cancer	0.000637	0.00125	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—GNAQ—ocular cancer	0.000612	0.0012	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—HRAS—ocular cancer	0.000611	0.0012	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—HRAS—ocular cancer	0.000608	0.00119	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TFDP1—ocular cancer	0.000606	0.00119	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—HRAS—ocular cancer	0.000605	0.00118	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—E2F3—ocular cancer	0.000603	0.00118	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—HRAS—ocular cancer	0.000602	0.00118	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—AKT1—ocular cancer	0.0006	0.00117	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CDKN2B—ocular cancer	0.000594	0.00116	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	0.000593	0.00116	CbGpPWpGaD
Amlexanox—FGF1—Disease—MAML2—ocular cancer	0.000593	0.00116	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—CDKN1A—ocular cancer	0.000592	0.00116	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CDKN1A—ocular cancer	0.000591	0.00116	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAML2—ocular cancer	0.000581	0.00114	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.000574	0.00112	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—HRAS—ocular cancer	0.000566	0.00111	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000566	0.00111	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—HRAS—ocular cancer	0.000566	0.00111	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—AKT1—ocular cancer	0.000565	0.00111	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—EP300—ocular cancer	0.000563	0.0011	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—E2F3—ocular cancer	0.000562	0.0011	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—HRAS—ocular cancer	0.000561	0.0011	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TFDP1—ocular cancer	0.000561	0.0011	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TP53—ocular cancer	0.000558	0.00109	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000557	0.00109	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000556	0.00109	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—HRAS—ocular cancer	0.000554	0.00108	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—E2F1—ocular cancer	0.000546	0.00107	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—AKT1—ocular cancer	0.000539	0.00106	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—AKT1—ocular cancer	0.000537	0.00105	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—AKT1—ocular cancer	0.000534	0.00105	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—HRAS—ocular cancer	0.000534	0.00105	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—AKT1—ocular cancer	0.000532	0.00104	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—HRAS—ocular cancer	0.000524	0.00103	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.000524	0.00103	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TFDP1—ocular cancer	0.000523	0.00102	CbGpPWpGaD
Amlexanox—IL3—Immune System—MDM2—ocular cancer	0.00051	0.000999	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—GNA11—ocular cancer	0.000507	0.000993	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAML2—ocular cancer	0.000506	0.000991	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000502	0.000982	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—AKT1—ocular cancer	0.0005	0.000979	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—AKT1—ocular cancer	0.0005	0.000979	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.0005	0.000979	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—AKT1—ocular cancer	0.000496	0.000971	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000491	0.000962	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—AKT1—ocular cancer	0.000489	0.000958	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAML2—ocular cancer	0.000481	0.000943	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—GNAQ—ocular cancer	0.000471	0.000923	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—AKT1—ocular cancer	0.000471	0.000923	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000471	0.000922	CbGpPWpGaD
Amlexanox—IL3—Immune System—CDKN1B—ocular cancer	0.000466	0.000912	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—AKT1—ocular cancer	0.000463	0.000906	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAML2—ocular cancer	0.000445	0.000872	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000443	0.000867	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GNA11—ocular cancer	0.000441	0.000864	CbGpPWpGaD
Amlexanox—FGF1—Disease—HDAC1—ocular cancer	0.000434	0.000849	CbGpPWpGaD
Amlexanox—IL3—Immune System—CDKN1A—ocular cancer	0.00043	0.000842	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HDAC1—ocular cancer	0.000425	0.000832	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GNA11—ocular cancer	0.00042	0.000823	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAML2—ocular cancer	0.000415	0.000813	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GNAQ—ocular cancer	0.00041	0.000804	CbGpPWpGaD
Amlexanox—IL3—Immune System—EP300—ocular cancer	0.000409	0.000801	CbGpPWpGaD
Amlexanox—S100A12—Immune System—MDM2—ocular cancer	0.000409	0.0008	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—MDM2—ocular cancer	0.000401	0.000785	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GNAQ—ocular cancer	0.000391	0.000765	CbGpPWpGaD
Amlexanox—FGF1—Disease—CDKN2B—ocular cancer	0.000389	0.000761	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GNA11—ocular cancer	0.000389	0.000761	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—HRAS—ocular cancer	0.000386	0.000756	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—MDM2—ocular cancer	0.000385	0.000754	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—HRAS—ocular cancer	0.000385	0.000754	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CDKN2B—ocular cancer	0.000381	0.000746	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CDKN1B—ocular cancer	0.000373	0.000731	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HDAC1—ocular cancer	0.00037	0.000724	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CDKN1B—ocular cancer	0.000366	0.000717	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GNA11—ocular cancer	0.000362	0.00071	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GNAQ—ocular cancer	0.000361	0.000708	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HDAC1—ocular cancer	0.000352	0.000689	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CDKN1B—ocular cancer	0.000352	0.000689	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—E2F1—ocular cancer	0.00035	0.000685	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CDKN1A—ocular cancer	0.000344	0.000674	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—AKT1—ocular cancer	0.000341	0.000667	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—AKT1—ocular cancer	0.00034	0.000666	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CDKN1A—ocular cancer	0.000338	0.000662	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GNAQ—ocular cancer	0.000337	0.00066	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CDKN2B—ocular cancer	0.000332	0.000649	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MDM2—ocular cancer	0.00033	0.000646	CbGpPWpGaD
Amlexanox—S100A12—Immune System—EP300—ocular cancer	0.000328	0.000642	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HDAC1—ocular cancer	0.000326	0.000638	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CDKN1A—ocular cancer	0.000324	0.000636	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—EP300—ocular cancer	0.000322	0.00063	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CDKN2B—ocular cancer	0.000316	0.000618	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—HRAS—ocular cancer	0.000306	0.0006	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—E2F1—ocular cancer	0.000304	0.000596	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HDAC1—ocular cancer	0.000304	0.000595	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CDKN1B—ocular cancer	0.000301	0.00059	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—AKT1—ocular cancer	0.000298	0.000583	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CDKN2B—ocular cancer	0.000292	0.000572	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—E2F1—ocular cancer	0.00029	0.000567	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCND1—ocular cancer	0.000287	0.000562	CbGpPWpGaD
Amlexanox—IL3—Immune System—HRAS—ocular cancer	0.00028	0.000548	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CDKN1A—ocular cancer	0.000278	0.000544	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CDKN2B—ocular cancer	0.000272	0.000533	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—AKT1—ocular cancer	0.00027	0.00053	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—E2F1—ocular cancer	0.000268	0.000525	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—EP300—ocular cancer	0.000264	0.000518	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—E2F1—ocular cancer	0.00025	0.000489	CbGpPWpGaD
Amlexanox—IL3—Immune System—AKT1—ocular cancer	0.000247	0.000484	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MDM2—ocular cancer	0.000234	0.000457	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MYC—ocular cancer	0.00023	0.000451	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TGFB1—ocular cancer	0.00023	0.00045	CbGpPWpGaD
Amlexanox—S100A12—Immune System—HRAS—ocular cancer	0.000224	0.000439	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—HRAS—ocular cancer	0.00022	0.000431	CbGpPWpGaD
Amlexanox—FGF1—Disease—MDM2—ocular cancer	0.000216	0.000422	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CDKN1B—ocular cancer	0.000213	0.000418	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—HRAS—ocular cancer	0.000211	0.000414	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MDM2—ocular cancer	0.000211	0.000414	CbGpPWpGaD
Amlexanox—S100A12—Immune System—AKT1—ocular cancer	0.000198	0.000388	CbGpPWpGaD
Amlexanox—FGF1—Disease—CDKN1B—ocular cancer	0.000197	0.000386	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CDKN1A—ocular cancer	0.000197	0.000385	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—HRAS—ocular cancer	0.000196	0.000384	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—AKT1—ocular cancer	0.000194	0.000381	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CDKN1B—ocular cancer	0.000193	0.000378	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—AKT1—ocular cancer	0.000191	0.000374	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—ocular cancer	0.000189	0.000371	CbGpPWpGaD
Amlexanox—FGF1—Immune System—EP300—ocular cancer	0.000187	0.000367	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—AKT1—ocular cancer	0.000187	0.000365	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCND1—ocular cancer	0.000184	0.00036	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MDM2—ocular cancer	0.000184	0.00036	CbGpPWpGaD
Amlexanox—FGF1—Disease—CDKN1A—ocular cancer	0.000182	0.000356	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HRAS—ocular cancer	0.000181	0.000354	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CDKN1A—ocular cancer	0.000178	0.000349	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MDM2—ocular cancer	0.000175	0.000343	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—AKT1—ocular cancer	0.000173	0.000339	CbGpPWpGaD
Amlexanox—FGF1—Disease—EP300—ocular cancer	0.000173	0.000339	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—HRAS—ocular cancer	0.000171	0.000335	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—EP300—ocular cancer	0.000169	0.000332	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CDKN1B—ocular cancer	0.000168	0.000329	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—AKT1—ocular cancer	0.000166	0.000325	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—HRAS—ocular cancer	0.000163	0.000318	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MDM2—ocular cancer	0.000162	0.000317	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCND1—ocular cancer	0.00016	0.000314	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CDKN1B—ocular cancer	0.00016	0.000313	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—AKT1—ocular cancer	0.00016	0.000313	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—AKT1—ocular cancer	0.000158	0.00031	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CDKN1A—ocular cancer	0.000155	0.000303	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCND1—ocular cancer	0.000152	0.000299	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MDM2—ocular cancer	0.000151	0.000296	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—AKT1—ocular cancer	0.000151	0.000295	CbGpPWpGaD
Amlexanox—FGF1—Disease—MYC—ocular cancer	0.000151	0.000295	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—HRAS—ocular cancer	0.00015	0.000295	CbGpPWpGaD
Amlexanox—FGF1—Disease—TGFB1—ocular cancer	0.00015	0.000294	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CDKN1B—ocular cancer	0.000148	0.00029	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MYC—ocular cancer	0.000148	0.000289	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CDKN1A—ocular cancer	0.000147	0.000289	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EP300—ocular cancer	0.000147	0.000289	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TGFB1—ocular cancer	0.000147	0.000288	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—AKT1—ocular cancer	0.000146	0.000286	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—AKT1—ocular cancer	0.000144	0.000281	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCND1—ocular cancer	0.000141	0.000276	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EP300—ocular cancer	0.00014	0.000275	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CDKN1B—ocular cancer	0.000138	0.00027	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CDKN1A—ocular cancer	0.000136	0.000267	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—AKT1—ocular cancer	0.000133	0.00026	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCND1—ocular cancer	0.000132	0.000258	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EP300—ocular cancer	0.00013	0.000254	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MYC—ocular cancer	0.000128	0.000252	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TGFB1—ocular cancer	0.000128	0.000251	CbGpPWpGaD
Amlexanox—FGF1—Immune System—HRAS—ocular cancer	0.000128	0.000251	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CDKN1A—ocular cancer	0.000127	0.000249	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MYC—ocular cancer	0.000122	0.00024	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TGFB1—ocular cancer	0.000122	0.000239	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—ocular cancer	0.000121	0.000237	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EP300—ocular cancer	0.000121	0.000237	CbGpPWpGaD
Amlexanox—FGF1—Disease—HRAS—ocular cancer	0.000118	0.000232	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HRAS—ocular cancer	0.000116	0.000227	CbGpPWpGaD
Amlexanox—FGF1—Immune System—AKT1—ocular cancer	0.000113	0.000222	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MYC—ocular cancer	0.000113	0.000222	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TGFB1—ocular cancer	0.000113	0.000221	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—ocular cancer	0.000106	0.000207	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MYC—ocular cancer	0.000106	0.000207	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TGFB1—ocular cancer	0.000105	0.000206	CbGpPWpGaD
Amlexanox—FGF1—Disease—AKT1—ocular cancer	0.000104	0.000205	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AKT1—ocular cancer	0.000102	0.0002	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HRAS—ocular cancer	0.000101	0.000198	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—ocular cancer	0.0001	0.000197	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HRAS—ocular cancer	9.61e-05	0.000188	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—ocular cancer	9.29e-05	0.000182	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AKT1—ocular cancer	8.91e-05	0.000174	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HRAS—ocular cancer	8.89e-05	0.000174	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—ocular cancer	8.66e-05	0.00017	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AKT1—ocular cancer	8.48e-05	0.000166	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HRAS—ocular cancer	8.29e-05	0.000162	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AKT1—ocular cancer	7.85e-05	0.000154	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AKT1—ocular cancer	7.32e-05	0.000143	CbGpPWpGaD
